ZTS Stock Analysis: Zoetis Inc - Class A
Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respira
- Latest close
- $69.83
- 20-day change
- -9.61%
- Trend state
- BEARISH
- Classification
- Healthcare · Drug Manufacturers - Specialty & Generic
Market context
Zoetis Inc - Class A moved -9.61% over the latest 20-session window. BullRecon currently classifies the broader setup as BEARISH.
Latest report
The latest cached company filing period (FY2025 · $9.5B revenue · $2.7B net income) is used alongside annual and quarterly history. Values remain tied to their reported period.
Six-dimension read
Profitability is currently the strongest dimension at 5.8/6, while Growth is the lowest at 3.3/6. Scores are comparative research signals, not forecasts.